Everest Medicines to Hold Investor Calls on Data Results from EVER001 Phase 1b/2a Clinical Study in Primary Membranous Nephropathy
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameEverest Medicines Ltd
-
Registration countryCayman Islands
-
IndustryMiscellaneous Healthcare: Products and Services
-
М/S&P/F
*** /*** /***









